SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-16-000772
Filing Date
2016-11-22
Accepted
2016-11-22 14:49:57
Documents
61
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a13011.htm 10-Q 412999
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 10053
3 EXHIBIT 32.1 exh32_1.htm EX-32.1 3212
  Complete submission text file 0001398432-16-000772.txt   6978834

Data Files

Seq Description Document Type Size
4 nphc-20160930.xml EX-101.INS 887144
5 nphc-20160930.xsd EX-101.SCH 68162
6 nphc-20160930_cal.xml EX-101.CAL 32579
7 nphc-20160930_def.xml EX-101.DEF 322593
8 nphc-20160930_lab.xml EX-101.LAB 418253
9 nphc-20160930_pre.xml EX-101.PRE 330850
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

IRS No.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 162012900
SIC: 2833 Medicinal Chemicals & Botanical Products